Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-011242

Options or other derivatives

  • Chief Scientific Officer acquired 41,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Biller Scott Chief Scientific Officer 2018-02-16 Grant or award · Stock option (right to buy) +33,000 33,000 D
Biller Scott Chief Scientific Officer 2018-02-16 Grant or award · Restricted stock units +8,250 8,250 D
Loading xslF345X03/doc4.xml…